Tourette syndrome is a neurological condition that has no cure but can be managed with various strategies—some of which are ...

There's a big stigma surrounding Tourette syndrome and other brain disorders, but Milan teacher Larry Biederman is working to break that by showing his students how they can be successful despite ...

Relmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma.

US CNS specialist Relmada Therapeutics has announced the acquisition of sepranolone, a Phase IIb ready neurosteroid, from ...

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

In PEOPLE's exclusive sneak peek at an upcoming episode of TLC's 'Baylen Out Loud', Baylen decides to try Botox for the first ...

Tourette syndrome is currently diagnosed about three times more frequently in males than in females. A new study finds that female individuals are less likely to be diagnosed with the syndrome, take ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...